Gnana Ruba Priya Muthaiya | Medicinal Chemistry | Best Researcher Award

Dr. Gnana Ruba Priya Muthaiya | Medicinal Chemistry | Best Researcher Award

Dayananda Sagar University, India

Dr. Gnana Ruba Priya Muthaiya is an accomplished pharmaceutical chemist and academician with advanced expertise in medicinal chemistry and drug design. Holding doctoral and postgraduate qualifications in pharmaceutical sciences, she has extensive experience in teaching, research, and mentoring across pharmacy disciplines. Her research focuses on computer-aided drug discovery, green synthesis, and anticancer therapeutics. With numerous peer-reviewed publications, patents, and scientific contributions, she has earned recognition for research excellence. Her work reflects a strong commitment to innovative drug development and impactful advancements in healthcare science.

Citation Metrics (Scopus)

70
50
30
10
0

Citations
60

Documents
1

h-index
1

Citations

Documents

h-index

Featured Publications


Artificial intelligence in screening: Models versus experiments


Drug Discovery Today (Cited by 93 · Year: 2022)

Sachin Dhawale | Medicinal Chemistry | Best Researcher Award

Assoc. Prof. Dr. Sachin Dhawale | Medicinal Chemistry | Best Researcher Award

Shreeyash Institute of Pharmaceutical Education and Research | India

Dr. Sachin Ashok Dhawale is a dedicated researcher in medicinal chemistry and pharmaceutical sciences, recognized for his contributions to drug design, molecular modeling, and synthetic chemistry. With a strong academic foundation including a PhD in Pharmacy, M.Pharm in Pharmaceutical Chemistry, and a B.Pharm degree, he has built extensive experience across academic and research environments, serving in teaching positions and contributing to funded research projects as a JRF and SRF under national scientific bodies. His scientific impact is reflected in 136 citations, an h-index of 6, and an i10-index of 4, supported by more than 25 Scopus-indexed publications, several as first or corresponding author, and cumulative impact exceeding 50. His research spans anticancer agents, antimicrobial molecules, molecular docking, natural product-based therapeutics, ADMET studies, and computational chemistry approaches. He has guided multiple undergraduate and postgraduate research projects, presented papers at national and international conferences, and published a specialized book on computer-aided drug design. His work has earned several recognitions including first-prize awards at competitive scientific events and fellowship support from national and state agencies. With expertise in advanced cheminformatics tools and synthetic techniques, he continues to contribute to innovative therapeutic discovery aimed at improving human health.

Profile: Google Scholar | Orcid

Featured Publications

Gandla, K., Islam, F., Zehravi, M., Karunakaran, A., Sharma, I., Haque, M. A., … Dhawale, S. A. (2023). Natural polymers as potential P-glycoprotein inhibitors: Pre-ADMET profile and computational analysis as a proof of concept to fight multidrug resistance in cancer. Heliyon, 9(9).

Singu, P. S., Kanugala, S., Dhawale, S. A., Kumar, C. G., & Kumbhare, R. M. (2020). Synthesis and pharmacological evaluation of some amide functionalized 1H-benzo[d]imidazole-2-thiol derivatives as antimicrobial agents. ChemistrySelect, 5(1), 117–123.

Dube, P. N., Sakle, N. S., Dhawale, S. A., More, S. A., & Mokale, S. N. (2019). Synthesis, biological investigation and docking study of novel chromen derivatives as anti-cancer agents. Anti-Cancer Agents in Medicinal Chemistry, 13.

Gawai, A. A., Kharat, A. R., Chorge, S. S., & Dhawale, S. A. (2023). Green synthesis of silver nanoparticles mediated Azadirachta indica extract and study of their characterization, molecular docking, and antibacterial activity. Journal of Molecular Recognition, 36(10), e3051.

Suryawanshi, R. M., Shimpi, R. B., Muralidharan, V., Nemade, L. S., Gurugubelli, S., … Dhawale, S. A. (2025). ADME, toxicity, molecular docking, molecular dynamics, glucokinase activation, DPP-IV, α-amylase, and α-glucosidase inhibition assays of mangiferin and friedelin for antidiabetic potential. Chemistry & Biodiversity, 22(5), e202402738.